In an exciting new study, Dr Kazuo Takayama (CiRA, Kyoto University) has successfully modelled the SARS-CoV-2 life cycle in undifferentiated iPSCs, which were previously uninfectable. This ground breaking research has shown how iPSCs and organoids can be used in COVID-19 drug discovery and to investigate differences in SARS-CoV-2 infection caused by variations in genetic background.
Dr Takayama gave a unique insight into his research at the ISSCR Virtual Annual Meeting 2021. You can find the on demand recording of the talk further down this page.